🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Virosomal influenza vaccine

Found 13 matching trials

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

PHASE1

The goal of the study is to assess the safety and immune response after vac...

Status

Completed

Location

Center for the Evaluation of Vaccination, Unit of Epidemiology and Social Medicine, University of Antwerp

Start Date

2012-06

Trial ID

NCT01617239

Treatments Being Tested

Virosomal influenza vaccine

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

The study is to assess whether the virosomal influenza vaccine for season 2...

Status

Completed

Location

CROSS-Research SA

Start Date

2012-07

Trial ID

NCT01631071

Treatments Being Tested

Virosomal influenza vaccine

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

PHASE3

Influenza (flu) viruses change continuously, therefore also the parts of vi...

Status

Withdrawn

Location

Site 1

Start Date

2006-06

Trial ID

NCT00345462

Treatments Being Tested

Trivalent virosomal influenza vaccine

Influenza Vaccination in Immunocompromized Patients

PHASE4

Evaluation of the immunogenicity and reactogenicity of two different formul...

Status

Completed

Location

Department of Infectious Diseases, Bern University Hospital

Start Date

2005-10

Trial ID

NCT00783380

Treatments Being Tested

Virosomal influenza vaccine Subunit influenza vaccine

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

PHASE3

The purpose of this study is to assess the humoral immune response and safe...

Status

Completed

Location

Covance Clinical Research Unit AG

Start Date

2011-10

Trial ID

NCT01412281

Treatments Being Tested

Virosomal influenza vaccine (AdImmune HA Antigen)Virosomal influenza vaccine (CSL HA Antigen)

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

PHASE3

The primary purpose of this study was to assess whether the protection affo...

Status

Completed

Location

Multiple Locations

Start Date

2007-03-14

Trial ID

NCT01307436

Treatments Being Tested

Epaxal Havrix 720

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

PHASE3

A study to assess whether the Northern Hemisphere 2009/2010 season influenz...

Status

Completed

Location

Guangxi Zhuang Autonomous Region CDC

Start Date

2009-10

Trial ID

NCT01310400

Treatments Being Tested

Inflexal V Inflexal V Agrippal

Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

PHASE2

The primary purpose of the original study was to assess whether the protect...

Status

Completed

Location

Sint-Vincentiusziekenhuis

Start Date

2004-06

Trial ID

NCT01405677

Treatments Being Tested

Epaxal 0.25 mL Epaxal 0.5 mL Havrix Junior 0.5 mL

Safety and Immunogenicity of Influenza H9 Vaccine in Humans

PHASE1

H9N2 influenza circulates in animal and poultry and has caused delf limitin...

Status

Completed

Location

University Hospitals Leicester

Start Date

2007-08

Trial ID

NCT00814229

Treatments Being Tested

H9N2 whole virus vaccine, IM, 1.5microg H9N2 whole virus vaccine, IM, 5microg H9N2 whole virus vaccine vaccine, IM, 15microg H9N2 whole virus vaccine, IM, 45microg H9N2 whole virus vaccine, alum, IM, 1.5microg H9N2 whole virus, alum, IM, 5microg H9N2 vaccine, whole virus, alum, IM, 15 microg H9N2 vaccine, whole virus, alum, IM, 45microg H9N2 virosome vaccine, IM, 1.5microg H9N2 virosomal vaccine, IM, 5microg H9N2 virosomal vaccine, IM, 15microg H9N2 virosomal vaccine, IM, 45microg H9N2 whole virus vaccine, ID, 5microg H9N2 whole virus vaccine, ID, 15microg

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

PHASE3

This is an open study of the use of AdimFlu-V (2012-2013 season) vaccine in...

Status

Completed

Location

Chang Gung Memorial Hospital at Linkuo

Start Date

2012-11-01

Trial ID

NCT01755364

Treatments Being Tested

AdimFlu-V

Previous Next